The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II, multicenter, open-label, non-randomized study of neoadjuvant chemotherapy NALIRINOX (5-FU/LV + oxaliplatin + nal-IRI) followed by chemoradiotherapy in patients with rectal cancer in a watch-and-wait program.
 
Cesar Gregorio Muñoz
Travel, Accommodations, Expenses - SERVIER
 
Maria Carmen Riesco Martinez
No Relationships to Disclose
 
Lisardo Ugidos
No Relationships to Disclose
 
Pilar Garcia-Alfonso
Consulting or Advisory Role - Amgen; Merck Serono; Pierre Fabre; SERVIER
Speakers' Bureau - Amgen; Merck Serono; Pierre Fabre; Sanofi; SERVIER
 
Rafael Álvarez
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Novocure (Inst); SERVIER (Inst)
Expert Testimony - Novocure
 
Paloma Peinado
No Relationships to Disclose
 
Marcial García
No Relationships to Disclose
 
Marisa Torres
No Relationships to Disclose
 
Antonio Cubillo
No Relationships to Disclose